Brexit developments for veterinary medicines February 2018

Brexit veterinary medicines regulatory affairs
28 February, 2018

The following developments relating to Brexit for veterinary medicines regulatory affairs have been published:

  • Germany - PEI is making preparations for increased capacity relating to Brexit, including provisions for taking over as RMS (Link).
  • Sweden - At a Brexit information day in Sweden, MPA confirmed their willingness to take over as RMS, free of charge (Link).
  • EMA - Updated Q & A: Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure (Link).
  • CMDv - Updated Q & A related to the UK's withdrawal from the EU with regard to national authorised VMPs (Link).
Business Units: 

Regulatory Outsourcing Options

Cyton’s dedicated regulatory procedures team can support you with:
 - Dossier preparation, submission & regulatory procedures
 - Regulatory intelligence and strategic planning
 - Life cycle management
 - Key person cover
 - Pharmacovigilance
 - Brexit support services